Document is current
Any future updates will be listed below
-
Authors
Priya, Khushbu
Rawat, Sonali
Das, Doli
Chaubey, Manaswi
Thacker, Hiral
Giri, Kiran
Singh, Shambhavi
Rai, Madhukar
Mohanty, Sujata
Rai, Geeta https://orcid.org/0000-0001-8162-8964
-
Funding
Funding for this research was provided by:
Science and Engineering Research Board (CRG/2022/002561/BHS)
- License Information
-
More Information
Article History
Received: 18 November 2024
Accepted: 29 January 2025
First Online: 29 March 2025
Declarations
:
: The authors declare that they have not use AI-generated work in this manuscript. 1. Title: Immunomodulatory studies in systemic lupus Erythematosus using Mesenchymal stem cells. This study was approved by the Institutional Ethics Committee of the All India Institute of Medical Science, New Delhi (Ref no: IC-SCR/116/20(R), dated: 14.06.2021). 2. Title: Immunomodulatory studies in systemic lupus Erythematosus using Mesenchymal stem cells. This study was approved by the Institutional Ethics Committee of the Institute of Medical Science, BHU (Ref. Dean/2020/ EC/Ro32, dated: 25.09.2019). Participants gave informed consent to participate in the study before taking part. 3. Title: Immunomodulatory effect of Mesenchymal stem cell in systemic lupus Erythematosus. All experimental protocols involving animals were reviewed and approved by the IAEC of the Institute of Science, BHU, India (Ref no.: BHU/DoZ/IAEC/ 2022-2023/003, dated: 24.07.2023).
: The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analysis, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
